Cholecystokinin

DB08862ApprovedInvestigationalWithdrawnProtein Based Therapies

Cholecystokinin ( also known as CCK or CCK-PZ) is a peptide hormone of the gastrointestinal system which is responsible for stimulating the digestion of fat and protein. Cholecystokinin, previously called... Cholecystokinin, previously called pancreozymin, is synthesized and secreted by enteroendocrine cells in the duodenum (the first portion of the small intestine) and leads to the release of bile and digestive enzymes.

Mechanism
Curator reviewed · 6 references
Primary indication
For use as a diagnostic aid for evaluation of gallbladder disorders.Curator reviewed
First approval
Canada, 1990
Also known as
CCK-PZ · Human CCK-33 · Human cholecystokinin-33 · Pancreozymin

Resolves to

Clinical / RWD

What you can answer from here — as of May 29, 2025

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3TransportersSubstrate / inhibitor direction, not just membership
Listed above
166Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 15 drug categories
Sign in
32+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cholecystokinin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account